DARE Dare Bioscience Inc.

1.01
-0.1  -9%
Previous Close 1.11
Open 1.1
Price To Book 0.94
Market Cap 11536383
Shares 11,422,161
Volume 412,427
Short Ratio 4.66
Av. Daily Volume 177,553

SEC filingsSee all SEC filings

  1. 424B5 - Prospectus [Rule 424(b)(5)] 181087989
  2. 424B3 - Prospectus [Rule 424(b)(3)] 181086146
  3. EFFECT - Notice of Effectiveness 181082553
  4. EFFECT - Notice of Effectiveness 181082556
  5. 8-K - Current report 181073467

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 2b trial to be initiated 2H 2018.
SST-6007
Female Sexual Arousal Disorder (FSAD)

SEC Filings

  1. 424B5 - Prospectus [Rule 424(b)(5)] 181087989
  2. 424B3 - Prospectus [Rule 424(b)(3)] 181086146
  3. EFFECT - Notice of Effectiveness 181082553
  4. EFFECT - Notice of Effectiveness 181082556
  5. 8-K - Current report 181073467
  6. S-3/A [Amend] - Registration statement under Securities Act of 1933 181063328
  7. 8-K - Current report 181053845
  8. CT ORDER - Confidential treatment order 181047249
  9. 8-K - Current report 181038086
  10. S-3 - Registration statement under Securities Act of 1933 181037769